For this purpose, we analyze by reverse transcription polymerase chain reaction (RT-qPCR) the mRNA expression level of LC3B gene in both RCC cell lines, which revealed a small significant increase in messenger expression between the SETD2-competent and the SETD2-deficent cell lines. This evidence concerns the gene SETD2 and renal cell carcinoma.